Buy EVIMED 60 (Raloxifene HCL) | DEUSPOWER

DIANAMED 10 (Methandienone)

EVIMED 60 (Raloxifene HCL) – Selective Estrogen Receptor Modulator

PRODUCT OVERVIEW

EVIMED 60 (Raloxifene HCL) from Deus Medical is a selective oestrogen receptor modulator from the benzothiophene family, used when the goal is structured oestrogen control rather than a full shutdown. In breast tissue it behaves as an antagonist, limiting unwanted oestrogenic activity; in bone and some other tissues it acts more like an agonist, helping to preserve the positive effects of oestrogen. That split behaviour is why it appears in both simple first-time PCT layouts and more advanced recovery plans. Each tablet contains 60mg of raloxifene hydrochloride and the product is supplied in two blister strips of 25 tablets, which keeps the tablets protected and makes it easy to follow a clear day‑by‑day schedule.

KEY FEATURES

Form: Oral tablets
Active compound: Raloxifene Hydrochloride
Concentration: 60mg per tablet
Brand: Deus Medical
Package content: 1 Box of 2x 25 Tablets, 60mg per Tablet
Also Known As: Evista, Keoxifene, Optruma

BENEFITS

The compound targets estrogen receptors differently depending on tissue type because this selective action allows it to block estrogen in breast tissue while mimicking estrogen beneficial effects in bone and uterine tissue.
Each tablet delivers exactly 60mg of raloxifene HCL, so researchers can structure their protocols with precision rather than approximation, and this consistency matters for maintaining predictable research outcomes.
The tablet format eliminates the need for injections or complex preparation methods, which means researchers who prefer oral administration routes find it accessible since protocol implementation becomes simpler and administration complexity reduces.
Raloxifene maintains integrity at room temperature when stored properly, so reliable research outcomes follow without requiring specialized storage equipment, and this stability contributes to the compound practicality in research settings.

USAGE INSTRUCTIONS

PCT Protocol: If you are using this alongside a steroid or testosterone cycle continue for the same duration as the cycle, so a 6 week cycle means 6 weeks of use.
Post-cycle PCT: Wait 2 to 3 days after completing your cycle, then take 40mg daily combined with Aromasin at 12mg daily.
Duration: Continue the PCT protocol for 4 weeks total.
Timing: You can take it with or without food, but try to keep the timing consistent each day.

IMPORTANT INFORMATION

Consult a Professional: Get health guidance before use because this is especially important for those who may have underlying health conditions, since SERMs can interact with other medications and affect hormonal systems.
Not Recommended:Strictly not for pregnant or breastfeeding women or those under 18 because the hormonal effects of SERMs can be particularly impactful during developmental stages and pregnancy.
Dosage Caution: Do not exceed recommended dosages mentioned in usage instructions because the 60mg standard dosage is established for specific applications, and exceeding it may increase the risk of adverse effects.
Duration: Follow recommended cycle duration guidelines and do not extend beyond 4 weeks for PCT protocols, since prolonged use beyond recommended durations may affect hormonal balance and recovery patterns.

STORAGE

Store below 30 degrees. Keep it away from light. Do not freeze it. Keep it out of reach of children.

LEGAL DISCLAIMER

This product is intended for use only according to applicable laws and regulations. The information here is for educational purposes. It does not replace medical advice. Misuse can bring health risks. Get professional guidance where needed.

WHY CHOOSE OUR EVIMED 60?

Deus Medical manufactures EVIMED 60 to ensure each tablet delivers exactly 60mg of raloxifene HCL, which lets you structure your intake with precision instead of guessing.
All concentration and composition details are clearly provided on the packaging and product labels, so this helps you make informed decisions.
The 2x25 tablet blister pack configuration makes it easy to track your usage while keeping the product in good condition throughout your research period.
Deus Medical maintains batch-to-batch integrity, which matters when you are following structured protocols where compound consistency counts.

EVIMED 60 – FAQ

WHAT ROLE DOES EVIMED 60 PLAY IN CYCLE SUPPORT OR PCT PLANNING?

EVIMED 60 is used to manage how oestrogen acts in the body, not to remove it completely. It blocks oestrogen at breast tissue where excess activity is unwanted, while allowing bone and other target sites to keep some of oestrogen’s supportive effects. In post‑cycle layouts it is often paired with an aromatase inhibitor so that total oestrogen levels and receptor activity are both controlled in a structured way.

IS EVIMED 60 INTENDED FOR ON-CYCLE OR POST-CYCLE USE?

The compound can be used in either phase, depending on how the plan is built. On‑cycle, it may run alongside aromatising compounds for continuous receptor coverage. For post‑cycle therapy, it is usually started 2 to 3 days after the final dose of the main cycle drugs, once levels begin to drop. From there it is kept in place for a defined period as part of the recovery framework.

HOW DOES EVIMED 60 COMPARE TO OTHER CYCLE SUPPORT OPTIONS?

EVIMED 60 differs from aromatase inhibitors and general “support” products because it is a SERM. Aromatase inhibitors reduce how much oestrogen is produced; EVIMED 60 changes how existing oestrogen interacts with specific tissues. This makes it a common choice where gynecomastia risk and bone density are both considerations, and where complete oestrogen removal would be counterproductive.

WHEN IS THIS TYPE OF SUPPORT PRODUCT COMMONLY INTRODUCED?

For on‑cycle use, EVIMED 60 is typically introduced at the start of the cycle and kept in until the final week. In post‑cycle protocols it is added shortly after the last injection or tablet of the main cycle, then maintained for around four weeks. That window is long enough to cover the early recovery phase while remaining practical in a fixed research or programme timeline.

WHO TYPICALLY BENEFITS MOST FROM USING EVIMED 60?

EVIMED 60 suits users who want targeted oestrogen control with an eye on long term structure, rather than aggressive suppression. It is relevant for those who plan around gynecomastia risk, bone health, or tissue‑specific modulation and who prefer an oral, clearly dosed SERM. It fits both methodical first‑time PCT setups and more advanced, data‑driven protocols where each compound has a clearly defined role.

WORKS WELL WITH

Brand: DEUS MEDICAL Model: DIANAMED 10

DIANAMED 10 (Methandienone) – 10mg Oral Anabolic Tablets by Deus Medical PRODUCT OVERVIEW DIANAMED 10 delivers a calibrated 10 mg dose of M..

13.00€ 0.026€/mg

ENCLOMIMED 25 (Enclomiphene Citrate)

Brand: DEUS MEDICAL Model: ENCLOMIMED 25

ENCLOMIMED 25 (Enclomiphene Citrate) - Oral SERM Tablets PRODUCT OVERVIEW ENCLOMIMED 25 (Enclomiphene Citrate) is an oral SERM tablet used ..

66.00€ 0.053€/mg

New

Brand: ASTERA LABS Model: AL LETROZOLE

Letrozole

LETROZOLE - High-Quality Aromatase Inhibitor for Estrogen Control and Hormonal Balance PRODUCT OVERVIEW Letrozole, commonly known by its ..

14.00€ 0.280€/mg

New Sold Out

Brand: BIAXOL Model: BS CYCLE SUPPORT

CYCLE SUPPORT

WHAT IS CYCLE SUPPORT: Cycle Support is a premium natural supplement developed specifically for athletes undergoing intense training cycles and pos..

45.00€

New Sold Out

Brand: ASTERA LABS Model: AL B-12

B-12

B-12 – High-Potency Vitamin B-12 Formula for Energy, Nerve Function, and Red Blood Cell SupportDOSAGE500 mcg/mlPACKAGE CONTENT1 vial containing 500 mc..

22.00€